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Unit, Alto Deba Integrated Health Care Organization, Mondragon, SpainA B S T R A C TObjectives: To develop a framework for the management of complex
health care interventions within the Deming continuous improve-
ment cycle and to test the framework in the case of an integrated
intervention for multimorbid patients in the Basque Country within
the CareWell project. Methods: Statistical analysis alone, although
necessary, may not always represent the practical signiﬁcance of the
intervention. Thus, to ascertain the true economic impact of the
intervention, the statistical results can be integrated into the budget
impact analysis. The intervention of the case study consisted of a
comprehensive approach that integrated new provider roles and new
technological infrastructure for multimorbid patients, with the aim of
reducing patient decompensations by 10% over 5 years. The study
period was 2012 to 2020. Results: Given the aging of the general
population, the conventional scenario predicts an increase of 21% in
the health care budget for care of multimorbid patients during the
study period. With a successful intervention, this ﬁgure should drop
to 18%. The statistical analysis, however, showed no signiﬁcantee front matter Copyright & 2017, International S
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ndence to: Myriam Soto-Gordoa, Research Unit, Aldifferences in costs either in primary care or in hospital care between
2012 and 2014. The real costs in 2014 were by far closer to those in the
conventional scenario than to the reductions expected in the objective
scenario. The present implementation should be reappraised, because
the present expenditure did not move closer to the objective budget.
Conclusions: This work demonstrates the capacity of budget impact
analysis to enhance the implementation of complex interventions. Its
integration in the context of the continuous improvement cycle is
transferable to other contexts in which implementation depth and
time are important.
Keywords: Deming cycle, discrete event simulation, integrated health
care, planning.
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The increasing prevalence of chronic diseases mainly because of
an aging population has led to a profound change in the
paradigm of health care. Approximately one in four adults have
two or more chronic conditions, and half of older adults have
three or more [1]. Therefore, health systems have changed in
perspective, and health care organizations previously concerned
mainly with treating acute problems are now focused on a
continuum-of-care approach [2]. That implies profound organiza-
tional changes [3,4]. Nevertheless, organizations are dynamic,
and interventions that require behavioral changes are difﬁcult to
implement. As ﬁrst shown in 1943, the adoption curve of an
innovation has an S shape, with a slow early phase affecting veryfew people, a rapid middle phase spreading widely, and a slow
third phase ending with incomplete penetration [5]. This means
that a substantial “steady-state” period during which the inter-
vention could be evaluated is unlikely to be attained quickly [6].
Furthermore, the impact of organizational changes depends
not only on the intervention content but also on their imple-
mentation. This is similar in pharmacoeconomics to the relation-
ship of the efﬁcacy of drugs to adherence to treatment [7].
Nevertheless, adherence can be managed in randomized con-
trolled trials to study the effectiveness of the drug, whereas the
deployment of an organizational change relates to personal
behavior. Implementing behavioral changes is not insurmount-
able, but it makes the economic evaluation of interventions
aimed at modifying organizational models challenging [8].ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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(PDCA) cycle, is an iterative four-step management method used
for the control and continuous improvement of processes and
products. A fundamental principle of the scientiﬁc method and
PDCA is iteration—once a hypothesis is conﬁrmed (or negated),
executing the cycle again will extend the knowledge further.
Repeating the PDCA cycle can bring the goal closer [9], and the
process itself helps to create a culture of critical thinkers [10].
Compared with more traditional health care research methods,
the PDCA cycle presents a pragmatic scientiﬁc method to address
the implementation of organizational changes [9].
The objective of the present study was to develop a framework
for the management of complex interventions within the contin-
uous improvement cycle over the long-term. The approach,
although adaptable to other contexts and diseases, was tested
with the case of an integrated health care intervention for multi-
morbid patients in the Donostialdea county in the Basque Country.Methods
The Framework
The transferability of randomized controlled trials in the context
of complex interventions has arisen in the literature in recent
years [11]. Unlike in the ﬁeld of pharmacoeconomics, the imple-
mentation of the intervention in this study depends on behav-
ioral changes, and therefore the need to assess them in the daily
routine emerges. Administrative claims databases can prove to
be very useful in measuring resource use and costs [12]. Further-
more, behavioral changes occur slowly, which implies that the
designed framework needs to cover the mid- to long-term vision.
A budget impact analysis (BIA) projects the burden of the target
population in the conventional or baseline scenario and analyzes
how this burden would change if the intervention achieved the
organizationally deﬁned goal. First, the BIA provides the long-term
perspective. This approach also lends understanding of the eco-
nomic burden of the disease, which is important for estimatingFig. 1 – Description of the approach that integrates simulation m
improvement cycle.future expenditures, especially in environments in which an aging
population will make a difference. Finally, it helps explore the
potential impact of the intervention [13,14] (Plan stage). Although a
BIA can be carried out more simply than by dynamic simulation
modeling, this technique is advantageous for representing the
complexities of health systems [15]. Because discrete event simu-
lation (DES) modeling handles time explicitly [16], we think it is the
most suitable dynamic model for carrying out BIA. Once the
intervention is deployed (Do stage), a statistical analysis is needed
to ascertain any changes in resource consumption in the subsequent
years (Check stage). In addition, the real costs, together with the
objective cost ﬁxed in the Plan stage, will determine whether the
trend is positive. The statistical analysis alone, although necessary,
may not always represent the practical signiﬁcance of the interven-
tion. Thus, the true economic impact of the intervention can be
ascertained by integrating the statistical results in the BIA. This
approach provides direct and understandable information for the
stakeholders [17]. If the intervention achieves the objective, then that
becomes the new standard (baseline) for the organization’s actions
going forward. On the contrary, if the Check stage shows no
improvement, then the existing standard remains and adjustments
or correction actions should be done (Act stage). Figure 1 shows
graphically the proposed framework for assessing complex inter-
ventions. It combines statistical analysis with the analysis of trends
on the basis of what would have occurred 1) in the baseline scenario
and 2) in an objective scenario.Case Study: Integrated Health Care Intervention for
Multimorbid Patients in the Basque Country
An integrated care approach supported by information and
communication technologies is being applied to determine how
to best respond to the complex needs of multimorbid patients in
the Basque Country as well as in six other European pilot sites
participating in the CareWell project [18]. The Basque Country
approach is focused on a vertical integrated model of health care
that refers to the delivery of primary and specialized care in aodeling and statistical analysis in Deming’s continuous
V A L U E I N H E A L T H 2 0 ( 2 0 1 7 ) 1 0 0 – 1 0 6102single health care organization [19,20]. This is described in depth
in Supplemental Materials found at 10.1016/j.jval.2016.08.002.Conceptual model
The natural history of multimorbidity is dynamic in persons,
characterized by frequent transitions between stable and unsta-
ble states over time. In our study, during the stable state in which
the patients stayed at home, they were cared for by primary care
professionals. When patients decompensated and required addi-
tional attention, they were referred to secondary care [21]. All
patients who used hospital care were initially evaluated by the
emergency department and were hospitalized only when the
department deemed it necessary. After the patients’ conditions
restabilized, they were discharged to their residence (Fig. 2).
A stratiﬁcation strategy was set up in the Basque Country to
identify those patients among the whole Basque population who
were at high risk of hospitalization and to forecast health care
utilization costs (costs of resource use and pharmacy). The strategy
was based on the Adjusted Clinical Groups, a system that measures
the morbidity burden of patient populations on the basis of disease
patterns, age, and sex. It relies on the diagnostic and/or pharma-
ceutical code information in administrative databases to assign to
each individual a risk score predicting resource consumption during
the next year compared with the total stratiﬁed population [22,23].
Higher risk foresees greater costs for the health care system. The
process of obtaining the risk score is explained extensively elsewhere
[24]. In our study, risk scores of 6.1 and higher were considered to be
suitable for case management. The criteria to select the target
population included the presence of two or more chronic conditions,
such as diabetes mellitus, heart failure, or chronic obstructive
pulmonary disease, and hospitalization at least once in the previousFig. 2 – Description of the conceptual model. A&E, accidyear. In the Donostialdea county, out of about 300,000 people, 1,113
multimorbid patients were eligible for the intervention in 2012.
The intervention was an integrated care program comprising an
interdisciplinary team including a general practitioner and a case
manager, with the goal of reducing the risk of patient decompensa-
tion measured by accident and emergency service use and hospital-
izations avoided. The integrated care model was implemented in
2012 and developed between 2013 and 2015; it has presently achieved
100% deployment [25]. On the basis of studies in the literature [26–
28], the Donostialdea Health Care Organization set its own objective
with Delphi [29] methodology. Decision makers, clinicians, and
epidemiologists were included in the study and they concluded that
the intervention for integrated health care could reduce decompen-
sations by an annual 2% beginning in 2014, with the goal of attaining
a total 10% reduction in 5 years.
Study design
First, a DES model [30] was built with the Arena Rockwell soft-
ware v14 (Rockwell Automation, Milwaukee, WI 53204, EE. UU) to
represent the care pathway for multimorbid patients, which was
characterized by frequent transitions to decompensation states
over time. The model outputs were consumption rates. By multi-
plying consumption rates in both scenarios by the unit costs
(Table 1), we determined the cost of illness of multimorbid
patients under both the conventional and integrated organiza-
tional systems. Combining the cost of illness under both organ-
izational systems allowed us to calculate costs in the BIA.
Second, a statistical analysis was carried out on the basis of
resource consumption calculated from each patient’s contacts in
terms of rate and cost. A univariate statistical testing approach was
ﬁrst used, and then a multivariate analysis by general linear models
was addressed [31].ent and emergency department; PC, primary care.
Table 1 – Unit costs for different services.
Service Unit cost (€)
General practitioner (health center) 27.2
General practitioner (home) 38.1
General practitioner (telephone) 13.6
Primary care nurse (health center) 12.0
Primary care nurse (home) 21.8
Primary care nurse (telephone) 6.0
Emergency 168.3
In-hospitalization mean stay 2273.7
Home hospitalization 2400.3
V A L U E I N H E A L T H 2 0 ( 2 0 1 7 ) 1 0 0 – 1 0 6 103Finally, real costs in 2014 were compared with those calcu-
lated in the BIA. Comparing subsequent real costs with the
calculated ones allowed us to analyze trends.Data sources
Epidemiological data (prevalence and mortality) and resource
consumption data were obtained from administrative databases.
Incidence rates of multimorbid patients by age and sex could not
be directly obtained from administrative databases. Knowing our
population prevalence and mortality, we estimated incidence
rates by age group using the Dismod II software, which is a tool
created by the World Health Organization (Geneva, Switzerland)
to measure the consistency of estimates of incidence, prevalence,
duration, and case fatality for diseases [32]. Costs were obtained
from the Basque Health Service accounting system in 2013
[33,34]. Projections of the National Institute of Statistics of Spain
[35] were used to determine the Spanish multimorbid population
between 2015 and 2020.Table 2 – Extrapolation till 2020 of the target population
objective scenarios.
Year 2013 2014 2015
Prevalence 1,148 1,158 1,169
Resource consumption
(contacts)
Traditional health care
PC
General practitioner 16,096 16,890 17,363
Nurse 9,753 9,997 10,295
A&E 3,870 3,965 4,077
Hospitalizations 846 857 874
Integrated health care
PC
General practitioner 16,096 17,775 17,850
Nurse 9,753 9,853 10,099
A&E 3,870 3,894 3,991
Hospitalizations 846 842 856
Costs
Traditional health care
PC 591,864 637,466 642,492
A&E and hospitalization 2,790,641 2,815,039 2,879,741
Total 3,382,505 3,452,505 3,522,233
Integrated health care
PC 591,864 642,455 647,203
A&E and hospitalization 2,790,641 2,764,185 2,819,541
Total 3,382,505 3,406,640 3,466,744
A&E, accident and emergency department; PC, primary care.Results
The main results of the BIA are presented in Table 2. In the ﬁrst
row, we show how the multimorbid patient population will grow
according to the aging population. We also show how contacts
with primary care (general practitioners and nurses), accident
and emergency, and hospitalizations will evolve over time.
Finally, we show the costs of these contacts. Considering the
aging of the general population, the multimorbid patient pop-
ulation in the Donostialdea county will increase by 8% by 2020. In
addition, because the target population is not only larger but also
older, the expenses will have increased by 21% under conven-
tional health care. Nevertheless, if interventions were successful
and reduced emergencies by an annual 2%, this budget would
decrease to 18%, with cumulative savings of more than half a
million euros during the study period (Table 2 and Fig. 3A).
By combining the results of the statistical analysis (see
Supplemental Materials) that showed no change in the resource
consumption by 2014 and that of the BIA, we provided new
insights about the implementation of the integrated intervention.
Figure 3B shows the real burden in 2014 and how the points
representing the following years (2015, 2016, etc.) could hypo-
thetically evolve. Because the points have not moved closer to
the objective line, we can state that deployment and/or inter-
vention must be reconsidered to begin the planning process
again.Conclusions
The Deming cycle, together with statistical analysis, is a well-
known tool for health care management, but to our knowledge, resource use, and costs both in standard and in
2016 2017 2018 2019 2020
1,194 1,198 1,227 1,235 1,250
17,183 17,897 18,075 18,295 18,408
10,853 10,688 10,977 11,381 11,743
4,283 4,441 4,599 4,776 4,949
916 956 992 1,031 1,063
18,176 18,355 18,480 19,087 19,079
9,916 10,056 10,617 10,582 11,145
4,165 4,303 4,419 4,542 4,681
895 930 952 983 1,011
648,663 657,100 661,612 666,483 672,277
3,014,704 3,144,243 3,264,686 3,387,948 3,501,821
3,663,367 3,801,343 3,926,298 4,054,431 4,174,098
657,318 657,197 665,635 674,134 680,980
2,947,098 3,057,102 3,133,845 3,234,630 3,328,886
3,604,416 3,714,299 3,799,480 3,908,764 4,009,866
Fig. 3 – Budget impact analysis: (A) Plan stage. (B) Check
stage including RWD for 2014 and hypothetical costs for the
following years. RWD, real-world data.
V A L U E I N H E A L T H 2 0 ( 2 0 1 7 ) 1 0 0 – 1 0 6104this work introduces for the ﬁrst time the BIA in the PDCA cycle
for continuous improvement of complex interventions.
Complex interventions are different from pharmacological
interventions in many ways. First, complex interventions are
usually formed by various components, hindering the identiﬁca-
tion of the target population. Moreover, complex interventions
follow a nonlinear pattern, which complicates foreseeing the
intervention’s likely harms and beneﬁts. But, probably the most
relevant difference is that implementation of complex interven-
tions relies on behavioral changes that are often subjected to
learning curves. If the intervention is evaluated too early in time,
that is, before it is sufﬁciently implemented, we may state that
the program did not work. Because economic evaluations based
only on early appraisals can be misleading [6], an iterative
approach should be taken. The four stages described in Deming’s
continuous improvement cycle mirror the scientiﬁc experimental
method by formulating a BIA, collecting data to test the hypoth-
esis, analyzing and interpreting the results, and making infer-
ences to iterate the hypothesis [36]. Moreover, the iterative
approach of the continuous improvement cycle should bring us
closer to the goal [9]. This is consistent with the point of view of
Drummond et al. [6] who suggest taking an interactive approach
to the clinical and economic evaluation of devices by revising the
expected results as increasing evidence of effectiveness in actual
use is collected.
Scientiﬁc conclusions and business or policy decisions should
not be based only on statistical signiﬁcance. Pragmatic consid-
erations often require binary “yes-no” decisions, but this does not
mean that P values alone can ensure that a decision is correct or
incorrect. Moreover, as reported by the American Statistical
Association, statistical signiﬁcance is not equivalent to scientiﬁc,human, or economic signiﬁcance, and so it does not measure the
size of an effect or the importance of the result [37]. Decision
makers need a better explanation of the practical relevance [38].
BIA translates the results of the statistical analysis into the
budget, providing direct and understandable information for the
stakeholders [17].
The inclusion of BIA in Deming’s continuous improvement
cycle has a triple aim. First, the BIA will provide understanding of
the economic burden of the disease. Second, it will help to
explore the potential impact of the intervention, according to
organizationally deﬁned goals [13,14]. This may be relevant
because, as previously noted, translation of the statistical anal-
ysis into the budget directly provides the stakeholders with
understandable information [17]. Finally, BIA provides a medium-
to long-term horizon for analyzing trends. This gives us a broader
perspective in assessing whether we are on track. Comparison of
the real resource consumption with the expected values over
time allows a comparison of the deviation between the goals
determined by the BIA and the present events occurring at each
of the stages. If the results begin to agree with the objective over
time, it will suggest that work is progressing in the right
direction. If, however, the results move further away from the
objective, as shown in this case, the deployment and/or the
intervention should be reconsidered. If the primary statistical
analysis shows positive results, a new BIA would have to be
performed to compare the conventional and integrated health
care interventions. The inclusion of organizationally set objec-
tives using qualitative methods such as Delphi studies has
various advantages. On one hand, objective setting is fundamen-
tal for continuous improvement [39], and on the other hand, it
allows the implementation process to be tailored to the charac-
teristics of the organization.
The BIA may be carried out via several approaches. The
simplest one would be to assume that the rate of resource use
per person would remain constant over the study period for each
age group. Costs would be obtained by multiplying the resource
consumption by the number of individuals in each age group.
Nevertheless, a more sophisticated approach, such as DES, would
provide more accurate results because it would enable the
representation of the natural history of the disease. The virtues
of dynamic models to represent complex systems have been
recently highlighted in a report of the International Society for
Pharmacoeconomics and Outcomes Research [15]. This applica-
tion of simulation modeling was also considered in a report
addressed to Barack Obama, the president of the United States, in
May 2014; an expert task force highlighted the uses of such
engineering tools to improve management of health systems [40].
Among the different dynamic models, DES seems particularly
adequate because it handles time explicitly, which is a funda-
mental requirement for this study. Its ﬂexibility also makes our
approach more generalizable, representing models of both simple
and complex levels of interaction.
The case study shown in this article is a practical application
of the approach. The BIA allowed us to estimate the burden of
multimorbid patients that would surpass €4 million during the
study period. Furthermore, it anticipated the increase in cost of
care for multimorbid patients because of aging in the Donostial-
dea county (Basque Country). It also showed the cost savings if
the program achieved the organizationally set objective of reduc-
ing unstable conditions in patients by an annual rate of 2%. This
was quantiﬁed in cumulative savings of more than half a million
euros. Decision makers were thus able to assess in advance the
size of the change they could expect from the deployment of the
integrated program in terms of budget expenditure. The fact
that the rate of primary care consultation costs did not increase
in the study period suggests that the intervention has not been
sufﬁciently implemented. With the passage of time and
V A L U E I N H E A L T H 2 0 ( 2 0 1 7 ) 1 0 0 – 1 0 6 105implementation improvement, it would be possible to analyze
trends. Representing the care process and the natural history of
multimorbid patients with DES allows prediction of the economic
burden associated with that population in the Donostialdea
county. This was made possible by the use of data and tools
with very different origins. We combined clinical evolution,
resource consumption, demographic trends, and epidemiological
data obtained with the Dismod II software, parametric survival
analysis, economic evaluation, and simulation to carry out a BIA
to inform the planning stage of the Deming cycle.
The framework developed within the CareWell project will
help its pilot sites to manage the implementation of interven-
tions aimed at maintaining long-term stability of multimorbid
patients and assess their outcomes. By setting objectives based
on evidence and including them in the BIA, managers can
evaluate whether the integrated health care intervention is
having the expected impact. This approach, however, has a broad
scope and is not limited to the management of integrated health
care interventions focused on improving care for multimorbid
patients. In fact, by tailoring the conceptual model of the BIA, this
approach could be used to determine the adequacy of any
complex intervention for which time and implementation are
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